• 31 Mar Product Spotlight – Trademark

     CH3 BIOSYSTEMS®   On March 20, 2018 CH3 BIOSYSTEMS became a registered trademark for the protection of the unique R&D products produced in Buffalo, New York and sold to customers all over the world....

  • 31 Mar Research Review Series (2 of 3)

    THE INTERSECTION OF CANCER AND PROTEIN METHYLATION   William Pratt, CH3 Biosystems Lab Intern Introduction   Protein arginine methyltransferases (PRMTs) are transcriptional coactivators, a type of coregulator that affects a transcription factor to increase the rate of transcription of a gene by recruiting general transcription......

  • 08 Mar Research Review Series (1 of 3)

    PRMT5 and Cancer  William Pratt, CH3 Biosystems Lab Intern   Protein methylation is a common post translational modification that has grown in importance as a research topic in recent years. The role of protein methylation in cancer is extremely complicated and thus very difficult to......

  • 21 Dec Product Spotlight

    PC12 Pheochromocytoma Cells     Advantage of PC12 Cells Every year thousands of people in the world are diagnosed with neurodevelopmental diseases and cancer. The need for better and more effective medications that can be brought to the market faster is on the rise. Each......

  • 10 Oct Research Spotlight

    Methyltransferase Inhibitors Recent exciting news in the field of personalized medicine of cancer patients: new developments on the collaboration between Epizyme and GlaxoSmithKline may contribute the advancement of cancer treatment research tremendously.  Additionally, there has been new progress made by CH3 BioSystems to create a......

  • 24 Aug Product Spotlight

    Cell Lines Cell lines are derived from normal or diseased tissue that is disaggregated and subjected to limited dilution to generate one or a few cells. Therefore, after several dozen rounds of division, cultures of cell line consist of cells with uniform genetic make-up and additionally homogenous......

  • 19 Oct Arginine methylation of RUNX1 affects peripheral CD4+ T cells in intact mice

    Arginine methylation of RUNX1 affects peripheral CD4+ T cells in intact mice RUNX1 (previously termed AML1) is a frequent target of human leukaemia-associated gene aberrations, and it encodes the DNA-binding subunit of the Core-Binding Factor transcription factor complex. RUNX1 expression is essential for the initiation......

  • 19 Oct NF kappa B joins other signaling molecules modified by methylation

    NF kappa B joins other signaling molecules modified by methylation In normal cells exposed to stress, the central transcription factor NF-κB is activated only transiently, to modulate the activation of downstream immune responses. However, in most cancers, NF-κB is abnormally activated constitutively, contributing thus to......

  • 14 Oct New Review of transcription factors and methylation

    New Review of transcription factors and methylation Methylation of lysine and arginine residues on histones has long been known to determine both chromatin structure and gene expression. In recent years, the methylation of non-histone proteins has emerged as a prevalent modification which impacts on diverse......

  • 12 Oct PRMT1 regulates cocaine actions in brain

    PRMT1 regulates cocaine actions in brain Recent evidence suggests that histone modifications play a role in the behavioral effects of cocaine in rodent models. Histone arginine is known to be methylated by protein arginine N-methyltransferases (PRMTs). Evidence shows that PRMT1 contributes to >90% of cellular......